|
Volumn 102, Issue 5 B, 1997, Pages 106-110
|
Postexposure chemoprophylaxis against HIV: What are the implications for people with AIDS and the organizations that serve them?
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIRETROVIRUS AGENT;
HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;
NUCLEOSIDE ANALOG;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CHEMOPROPHYLAXIS;
CLINICAL PROTOCOL;
CONFERENCE PAPER;
EPIDEMIC;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT;
HEALTH CARE PERSONNEL;
HEALTH CARE POLICY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION RISK;
LAW;
MEDICAL ETHICS;
OCCUPATIONAL EXPOSURE;
ORGANIZATION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
ANTI-HIV AGENTS;
ENVIRONMENTAL EXPOSURE;
ETHICS, MEDICAL;
HEALTH PERSONNEL;
HIV INFECTIONS;
HUMANS;
INFECTION CONTROL;
NEW YORK;
OCCUPATIONAL EXPOSURE;
|
EID: 0030842078
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9343(97)00073-9 Document Type: Conference Paper |
Times cited : (1)
|
References (10)
|